Newsom committed California to making its own insulin. It’s at least a year behind his schedule
Gov. Gavin Newsom’s ambitious plan to produce a cheap, generic insulin for the 3.2 million Californians with diabetes is ...
Insulin Prices Dropped. But Some Poor Patients Are Paying More.
A law that coaxed companies to lower the price of drugs came with a little-known consequence: smaller discounts for ...
pharmaphorum2d
Novo Nordisk: survival of the fittest applies in diabetes and obesity market
It became the first drug approved to ... on further innovation in insulin – but it knows it has to up its game, especially as biosimilar versions of Sanofi’s Lantus are now gaining ground ...
The Baltimore Sun2d
Baltimore City school system sues drug companies over allegedly inflated price of insulin
The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug manufacturers for allegedly colluding to inflate the cost of insulin.
CNN25d
There’s still no generic Ozempic, but a lower-priced daily injected GLP-1 is coming
Liraglutide, sold under the brand name Victoza for diabetes, is an earlier iteration in the same class as semaglutide, the active ingredient in Ozempic. Both are sold by Danish drug giant Novo ...
New York Post25d
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...
pharmaphorum5d
Civica plans shake-up of insulin sector with low-cost biosimilars
The biosimilars – which will be interchangeable with Sanofi's Lantus (insulin glargine), Novo ... They will use drug substance made by GeneSys Biologics but will be made at Civica's ...
BioPharma Dive4h
Medicare will negotiate Novo’s GLP-1 drug price. Here’s what that means for Ozempic, Wegovy.
Novo sells semaglutide as Ozempic and Rybelsus for diabetes and as Wegovy for obesity. In price talks, CMS will treat the different forms as a single product.
Fox News4d
Weiss Report: Hunter’s drug use can’t explain away not paying taxes on money earned by 'last name'
Special Counsel David Weiss' final report on his years-long investigation into Hunter Biden determined the first son's drug abuse could ... earned off of his "last name and connections." ...
Fierce Healthcare3d
FTC: Big 3 PBMs generated $7.3B from specialty generic drug markups
The FTC’s findings—which analyzed 51 specialty generic drugs from 2017 to 2022—showed these pharmacy benefit managers’ (PBMs') affiliated pharmacies spun up $7.3 billion in excess revenue ...
U.S. News & World Report22d
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA ... condition that occurs when the body does not use insulin well and cannot keep blood sugar at normal ...